This week, CBS News reported that Moderna's early data from their vaccine trials show 94.5% efficacy, with 5 vaccine recipients included in the trial's 95 confirmed cases, and…
Alessia Cavazza, PhD, of Great Ormond Street Institute of Child Health (ICH) at University College London, discusses her research related to the potential of emerging gene-editing technologies, particularly…
Carlos Del Rio, MD, Executive Associate Dean at Emory School of Medicine & Grady Health System, breaks down the four phases of clinical trials and discusses how the…
In the GUIDED study, pharmacogenomic testing significantly improved response and remission rates for difficult-to-treat depression patients over the standard of care.
In this video, recorded at the World Stem Cell Summit 2019, Julie Allickson, PhD, discusses past and current research conducted at the Wake Forest University School of Medicine’s…
Historically, high-sensitivity diagnostic testing for many common diseases consisted of sending samples to an offsite laboratory and potentially waiting hours or days before results were attained and shared…
Scientists at École Polytechnique Fédérale de Lausanne (EPFL) have developed a small laboratory-in-a-box capable of housing and feeding a colony of C. elegans nematodes (roundworms) and testing the…
With the aid of single-cell sequencing technology, researchers at Harvard Medical School have mapped the beginnings of the biological development of both zebrafish and frogs from a single-cell…
